Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001567892-16-000058
Filing Date
2016-02-02
Accepted
2016-02-02 17:02:39
Documents
107
Period of Report
2015-12-25

Document Format Files

Seq Description Document Type Size
1 10-Q mnkq110-q122515.htm 10-Q 1939299
2 EXHIBIT 31.1 mnkexhibit311122515.htm EX-31.1 19989
3 EXHIBIT 31.2 mnkexhibit312122515.htm EX-31.2 20043
4 EXHIBIT 32.1 mnkexhibit321122515.htm EX-32.1 7315
  Complete submission text file 0001567892-16-000058.txt   14078054

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnk-20151225.xml EX-101.INS 3888249
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20151225.xsd EX-101.SCH 87282
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnk-20151225_cal.xml EX-101.CAL 125376
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnk-20151225_def.xml EX-101.DEF 597401
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20151225_lab.xml EX-101.LAB 1021693
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20151225_pre.xml EX-101.PRE 756058
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35803 | Film No.: 161381715
SIC: 2834 Pharmaceutical Preparations